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Objective: Operations coupled with cardiopulmonary bypass may provoke a sys-
temic inflammatory response, and it has been suggested that this responses causes
capillary leakage of proteins, edema formation, and even organ failure. However,
capillary leak syndrome is mainly a clinical diagnosis and has not been verified as
yet by actual demonstration of protein leakage from the circulation. We have there-
fore measured the disappearance of labeled plasma protein before and after car-
diopulmonary bypass.
Methods: Sixteen patients scheduled for elective coronary artery bypass grafting
were enrolled in a prospective controlled study. The cardiopulmonary bypass circuit
was primed with crystalloids only. Tumor necrosis factor α, interleukin 6, inter-
leukin 8, anaphylatoxin C3a, and terminal complement complex C5b9 levels were
determined before, during, and 3 hours after cardiopulmonary bypass. The trans-
vascular escape rate of plasma protein from the intravascular compartment was
assessed by measuring the disappearance of intravenously injected Evans blue dye
before and during the third hour after cardiopulmonary bypass.
Results: A significant inflammatory response could be demonstrated by means of
the 5 measured mediators after bypass. The maximal increase, as compared with the
baseline value, was found for interleukin 6 (36-fold). The transvascular escape rate
of Evans blue dye was similar before and after bypass (7.6 ± 0.6%/h vs 7.3 ±
0.6%/h).
Conclusions: The above data confirm the systemic inflammatory response induced
by cardiopulmonary bypass. Contrary to expectations, the transvascular escape rate
of Evans blue dye did not change when comparing values before and after bypass.
The data do not support the concept of increased protein leakage in the exchange
vessels after bypass. We were unable to demonstrate a capillary leak syndrome.
Cardiopulmonary bypass (CPB) induces a well-described systemicinflammatory response syndrome (SIRS).1 A number of patientshave organ dysfunction, which may delay postoperative recoveryand may influence morbidity and mortality.2,3 SIRS has beendefined by the American College of Chest Physicians/Society ofCritical Care Medicine in a consensus conference.4 SIRS after CPB
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may lead to adult respiratory distress syndrome and multi-
organ failure by means of the same mechanisms that occur
in septic conditions. The release of a variety of inflamma-
tory mediators has been implicated in the pathogenesis of
SIRS during CPB: tumor necrosis factor α (TNF-α) and
interleukin (IL) 1, IL-6, and IL-8.5 Lipid and arachidonic
metabolites, platelet-activating factor, and activation of the
coagulation cascade are also involved in the inflammatory
response and in a physiologic anti-inflammatory reaction.6
It has been hypothesized that capillary leak syndrome is
induced by the above-described inflammatory reaction.7
Capillary leak syndrome is defined as a shift of fluid and
protein from the intravascular to the interstitial space, which
results in hypovolemia.8 However, capillary leak syndrome
after CPB has only been clinically diagnosed and has not
yet been verified by the determination of protein leakage
from the circulation. Increased capillary permeability after
CPB was demonstrated for isolated organs (eg, in the lungs9
and also in the gut10). Concerning the whole body, in con-
trast, no capillary leakage had been measured in an animal
model after CPB.11 Therefore, the disappearance of labeled
plasma protein (PP), plasma cytokines, and complement
were measured before and after CPB in patients.
Methods
The present investigation was performed in accordance with the
principles of the declaration of Helsinki (1964) and its later revi-
sions. The study protocol was approved by the ethical committee
of the Technical University of Munich. Written informed consent
was obtained from each patient.
The study was performed in 16 consecutive patients with stable
angina in New York Heart Association class III who were scheduled
for elective coronary artery bypass grafting (CABG). Exclusion cri-
teria were as follows: age greater than 75 years; body weight greater
than 30% more than or less than ideal body weight; left ventricular
ejection fraction of 40% or less; hemodynamic instability or emer-
gency operations; additional valvular diseases; complete bundle
branch block; third-degree atrioventricular block; renal (creatinine
level >1.2 mg/dL) or hepatic failure; and hematocrit level of less
than 30%. Monitoring included continuous recording of electrocar-
diography, ST-segment analysis of leads II and V5, and pulse
oximetry (Marquette, Milwaukee, Wis). Before induction of anes-
thesia, a 20-gauge radial artery catheter (Arrow, Reading, Pa), a pul-
monary artery catheter (7.5F; Baxter, Irvine, Calif) through the right
internal jugular vein with an 8.5F introducer sheath (Arrow,
Reading, Calif ), and 2 large-bore intravenous catheters were placed.
After orotracheal intubation, mechanical ventilation with 100%
oxygen was provided. Tidal volume was adjusted to achieve nor-
moventilation and controlled by means of mass spectrometry and
blood gas analysis to maintain normal levels of arterial carbon diox-
ide. Measurements of hemodynamics included heart rate (HR),
mean arterial pressure, mean pulmonary artery pressure, pulmonary
capillary wedge pressure, and cardiac output. Cardiac output was
measured in triplicate by the thermodilution technique. The cardiac
index and systemic vascular resistance were calculated on the basis
of the patient’s body surface area.
Anesthesia Technique
Induction of anesthesia was done as a total intravenous technique.
Anesthesia was induced with 1 µg/kg sufentanil, 0.04 mg/kg mi-
dazolam, and 0.1 mg/kg pancuronium; an additional dose of 6 µg/kg
sufentanil and 0.3 mg/kg midazolam was given before sternotomy,
followed by an infusion of 0.5 µg · kg–1 · h–1 sufentanil and 0.02
mg · kg–1 · h–1 midazolam until the end of the operation. A preop-
erative volume load with hydroxyethylstarch (500 mL) was used
for the purpose of avoiding a drop in arterial blood pressure caused
by induction of anesthesia. Every patient did receive the volume
before starting the measurement and an infusion of a low dose of
dopamine (3 µg · kg–1 · min–1), which was used throughout the pro-
cedure for maintenance of adequate urine output. Before separation
from CPB, dopamine was increased to 5 µg · kg–1 · min–1. After ter-
mination of CPB, the infusion rate was set according to the
Figure 1. Study protocol to assess the transvascular escape rate of albumin (TER) and the inflammatory response to
CPB in patients undergoing CABG. Plasma albumin was labeled by means of intravenous Evans blue dye.
Hemodynamic measurements included HR, mean arterial pressure (MAP), central venous pressure (CVP), cardiac
index (CI ), and systemic vascular resistance (SVRI). COP, Plasma colloid osmotic pressure.
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patient’s circulatory state. A cardiac index of 2.3 L · min–1 · m–2 or
greater and a mean arterial pressure of 60 mm Hg or greater were
the targets. In the intensive care unit the patients were sedated with
0.25 µg · kg–1 · h–1 sufentanil and 0.01 mg · kg–1 · h–1 midazolam.
CPB Technique
The extracorporeal circuit was primed with 1500 mL of lactated
Ringer solution supplemented by 100 mmol of sodium bicarbon-
ate, 5000 IU of heparin (Ratiopharm, Ulm, Germany), and 2 × 106
KIU of aprotinin. CPB was instituted at a flow rate of 2.4 L · min–1
· m2 body surface area after systemic heparinization. The rectal
temperature was reduced to 28°C by means of cooling on bypass.
After crossclamping the aorta, 1000 mL of cold crystalloid car-
dioplegic solution (Bretschneider = Custodiol; Köhler Chemie,
Alsbach-Hähnlein, Germany) was administered. The remaining
blood of the bypass circuit was prepared with a Cell Saver
(Haemonetics, München, Germany) before retransfusion.
Protocol of Data Assessment
The protocol of data assessment is shown in Figure 1. The follow-
ing variables were assessed: central venous pressure, mean arterial
pressure, HR, cardiac index, systemic vascular resistance, and
plasma levels of TNF-α, IL-6, IL-8, anaphylatoxin C3a, and ter-
minal complement complex C5b9. Data were sampled before skin
incision, immediately before the end of CPB, 2 hours after CPB,
and 3 hours after CPB.
The escape rate from plasma of intravenously injected Evans
blue dye was determined after induction of anesthesia and during
the third hour after weaning from CPB. The blood samples for
measurement of Evans blue dye were also analyzed for PP con-
centration and plasma colloid osmotic pressure.
Plasma Analyses
PP concentration was measured by a using biuret test kit
(Boehinger Mannheim, Mannheim, Germany). Plasma colloid
osmotic pressure was determined with a membrane osmometer
(Gonotec, Berlin, Germany; molecular mass cutoff, 10 kd).
Plasma concentration of TNF-α, IL-6, and IL-8 was assessed by
using 2-site chemiluminescent enzyme immunometric assays
(Immulite System; Diagnostic Products Corporation, Los Angeles,
Calif ). Plasma levels of C3a and C5b9 were analyzed with
enzyme immunometric assays (Innogenics, Heiden, Germany).
Escape of Plasma Albumin, Plasma Volume, and
Intravascular Protein Pool
The transvascular escape rate of PP from the intravascular com-
partment (TER) was assessed by measuring the disappearance of
intravenously injected Evans blue dye (Ophthalmic Laboratories,
Brookvale, Australia). The method has been previously described
and discussed in detail.11
Blood samples were taken before the first injection of Evans
blue dye to determine the blank absorbance of plasma (7 samples
within 0.5 hours). After intravenous injection of Evans blue dye
(0.2 mg/kg), samples were obtained every 10 minutes (at 10, 20,
30, 40, 50, and 60 minutes). The absorbance of plasma was deter-
mined in a spectrophotometer (Lamda 40; Perkin Elmer, Neuried,
Germany) at a λ value of 620 nm and a λ value of 740 nm. Linear
regression was calculated from the absorbance of undyed plasma
(A) at these 2 wavelengths:
A620 = a + b × A740 (1)
The absorbance of dyed plasma at 620 nm (Evans blue dye
[EB620]) was corrected for blank absorbance calculated by (1) and
from the following:
EB620corr = EB620 – (a + b × EB740) (2)
Specific protein dying (sEB) was calculated from (2) and PP con-
centration:
sEB = EB620corr/PP (3)
The decay of sEB with time was fitted as follows:
sEBt = sEB0 × e-k × t (4)
using the following transformation:
ln(sEBt) = [ln(sEB0)] – k × t (5)
with sEB0 indicating theoretic sEB at the time of dye injection and
immediate complete mixing with plasma volume, sEBtindicating-
sEB at any time t, and k indicating the disappearance rate constant.
sEB0 and k were obtained by calculating the linear regression from
the sampling times t and the corresponding sEBt values.
TER was calculated as follows:
TER = (1 – e–k × 60) × 100 [% × h–1] (6)
Plasma volume (PV) was calculated from the injected dose of EB
(EBi) and EB0:
PV = EBi /EB0 (7)
with EB0 indicating sEB0 × PP (see [3]).
TABLE 1. Demographic and operative data of 16 patients
undergoing CABG
Age (y) 61 ± 3
Sex (M/F) 14/2
NYHA class III (n) 16
Higgins score12 2.1 ± 0.3
EF (%) 62 ± 3
Weight (kg) 81 ± 2
No. of patients with diabetes 6
No. of patients with peripheral vascular disease 8
Operative time (min) 207 ± 9
CPB time (min) 79 ± 5
Crossclamp time (min) 54 ± 4
No. of bypasses 2.8 ± 0.1
Postoperative ventilation (h) 14 ± 4
NYHA, New York Heart Association; EF, ejection fraction.
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The intravascular protein pool (IVP) was calculated from the
PP concentration and from plasma volume as follows:
IVP = PP × PV (8)
Statistical Analysis
The data are presented as means ± SEM. The data were subjected to
Friedman distribution-free 2-way analysis of variance. The signifi-
cance of differences between control and subsequent data were eval-
uated by the Wilcoxon matched-pairs signed-rank test at a P value
of less than .05 (2-tailed). The statistical software SPSS 10.0 for
Windows (SPSS, Inc, Chicago, Ill) was used for these calculations.
Results
Surgical Data
Surgical data are given in Table 1.12 The operation time
ranged from 155 to 300 minutes (mean, 207 minutes). The
CPB time was 43 to 109 minutes (mean, 79 minutes). The
aorta was crossclamped for 28 to 80 minutes (mean, 54
minutes). The number of the distal coronary artery anasto-
moses was 2 to 3 (mean, 2.8). Except for 1 patient, a left
thoracic artery was used in all cases to bypass the left ante-
rior descending artery vessel. All patients were weaned
from CPB without problems and showed an uneventful
postoperative recovery.
Hemodynamics
The hemodynamic data before and after the operation are
summarized in Table 2. HR was 54 ± 2 beats/min before
skin incision and increased to 80 to 90 beats/min during the
third hour after the operation. Mean arterial blood pressure
was elevated from 80 ± 3 to 98 ± 4 mm Hg 3 hours after
CPB. Central venous pressure during the third hour after
CPB was not significantly different from the control level.
Cardiac index was increased from 2.9 ± 2 to about 4 L ·
min–1 · m–2. At the beginning of the third hour after CPB,
systemic vascular resistance was significantly lower (–15%)
than before the operation.
Systemic Inflammatory Response
Data on systemic inflammatory response are given in Table
3. TNF-α was doubled at the end of CPB and remained at
this level until 3 hours after CPB. IL-6 was approximately
15-fold greater than the baseline value at the end of CPB
and further increased to a 36-fold level during the next 3
hours. IL-8 was run in parallel with IL-6 but reached only a
4-fold level 3 hours after CPB. C3a and C5b9 were elevated
7- and 6-fold, respectively, at the end of CPB and decreased
after CPB. Three hours after CPB, C3a and C5b9 were 5-
and 2-fold baseline values, respectively.
PP-related Data
PP-related data are given in Table 4. Plasma volume was
about 53 mL/kg before the operation. The values obtained 2
hours after weaning from bypass were not systematically
different from the pre-CPB values. Plasma colloid osmotic
pressure was 22.7 ± 0.7 mm Hg before starting the surgical
intervention. Three hours after CPB, it was reduced to 20.6
± 0.7 mm Hg. The intravascular PP pool was calculated as
3.09 ± 0.16 g/kg before the operation. Two hours after CPB,
it was decreased to 2.29 ± 0.17 g/kg.
The decay of the specific color of PP after intravenous
injection of Evans blue dye was 7.6% ± 0.6%/h before the
operation. During the third hour after CPB, the mean escape
rate of the dye was 7.3% ± 0.6%/h. The 2 measurements
showed no systematic difference. The postoperative/preop-
erative ratio of the paired determinations was 1.04 ± 0.11.
TABLE 2. Hemodynamic data
Preoperative CPB + 2 h CPB + 3 h
HR (beats/min) 54 ± 2 82 ± 3* 91 ± 3
MAP (mm Hg) 80 ± 3 85 ± 3 98 ± 4*
CVP (mm Hg) 9.5 ± 0.7 7.3 ± 0.6 9.0 ± 0.9
CI (L · min–1 · m–2) 2.9 ± 0.2 3.8 ± 0.2* 4.3 ± 0.3
SVRI (dyne · s · cm–5 · m–2) 2090 ± 150 1733 ± 155* 1804 ± 158
MAP, Mean arterial pressure; CVP, central venous pressure; CI, cardiac
index; SVRI, systemic vascular resistance.
*P < .05 versus preoperative values.
TABLE 3. Inflammatory mediators
Preoperative CPB end CPB + 2 h CPB + 3 h
TNF-α (pg/mL) 5.7 ± 0.7 11.8 ± 1.8* 10.2 ± 1.3* 9.4 ± 0.9*
IL-6 (pg/mL) 5.3 ± 0.2 77 ± 34* 187 ± 63* 197 ± 31*
IL-8 (pg/mL) 5.0 ± 0.003 18.5 ± 4.2* 18.4 ± 2.9* 20.8 ± 2.8*
C3a (ng/mL) 291 ± 24 1760 ± 90* 1442 ± 86* 1220 ± 85*
C5b9 (ng/mL) 83 ± 8.4 414 ± 38* 207 ± 24* 122 ± 13*
*P < .05 versus preoperative values.
TABLE 4. Plasma volume, serum protein, intervascular pro-
tein pool, transvascular escape rate of Evans blue dye from
plasma, and plasma colloid osmotic pressure
Preoperative values 3-h Postoperative values
PV (mL/kg) 53 ± 3 53 ± 3
SP (g/dL) 6.4 ± 0.1 4.6 ± 0.2*
IVP (g/kg) 3.09 ± 0.16 2.29 ± 0.17*
TER (%/h) 7.6 ± 0.6 7.3 ± 0.6
COP (mm Hg) 22.7 ± 0.7 20.6 ± 0.7*
PV, Plasma volume; SP, serum protein; IVP, intravascular protein pool;
TER, transvascular escape rate of Evans blue dye from plasma; COP,
plasma colloid osmotic pressure.
*P < .05 versus preoperative values.
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The present study in patients undergoing CABG confirms
that CPB in combination with cardioplegic cardiac arrest is
followed by a systemic inflammatory response,5 which was
not associated with an increased disappearance rate of
labeled PPs, whereas the intravascular protein content was
reduced after CPB. These results, however, give no simple
answer to the question of the existence of a capillary leak
syndrome after CPB.
The capillary leak syndrome is characterized by general-
ized edema formation and ascites caused by an increase in
microvascular permeability to PPs, which is related to
inflammatory cytokines and the activation of the comple-
ment system.8 The existence of a capillary leak syndrome
related to CPB in cardiac surgery has been repeatedly sug-
gested for pediatric patients.7,13,14 It has been concluded
that this is the case from a decrease in PP concentration
soon after the onset of CPB.7 PP concentration, however,
reflects not only the intravascular protein pool but also
changes in plasma water, which may be increased after
institution of CPB, depending on the priming volume of the
extracorporeal circuit, on the type of cardioplegia, and on
subsequent fluid substitution. Furthermore, for the follow-
ing reason, it seems rather unlikely that the inflammatory
response to CPB causes a pathologic protein extravasation
early during CPB, as described elsewhere.7 The inflamma-
tory response is moderate during CPB but becomes most
pronounced 2 to 4 hours after CPB.5 Therefore, in the
present study the disappearance of Evans blue dye was
assessed during the third hour after CPB.
Assessment of Transvascular Protein Leakage
Microvascular leakage of PPs is monitored by the disap-
pearance rate of intravascularly applied labeled proteins. In
the present study endogenous PPs were labeled in vivo with
Evans blue dye. The disappearance rate of Evans blue dye
reflects the extravasation of protein if the dye is readily
bound to protein. Evans blue dye binds firmly to albumin
(>99.2%), and the Evans blue dye–binding capacity of albu-
min is 13 mol of Evans blue dye per mole of albumin.15 For
the present study, it can be calculated that only 1 of 1000
binding sites were occupied. Therefore, unbound Evans
blue dye should not have been present, and the calculated
disappearance rate of Evans blue dye represents the trans-
vascular leakage of albumin.
Baseline Disappearance Rate of Albumin
Studies in conscious, healthy men showed a mean disap-
pearance rate for albumin of 4.5%/h to 5.5%/h16-18 or
7.4%/h to 8.5%/h.19-21 The present baseline data correspond
with these rates but do not necessarily represent normal val-
ues. The standard protocol of anesthesia included a preoper-
ative volume load with hydroxyethylstarch (500 mL) and an
infusion of a low dose of dopamine (3 µg · kg–1 · min–1). The
volume load increased plasma volume, and a 25% increase
in plasma volume by albumin or dextran was shown to
increase the disappearance rate of albumin from less than
5%/h to 8%/h.18 Furthermore, the patients showed a rather
high central venous pressure caused by the volume load and
positive-pressure ventilation, and an elevation in venous
pressure increases the extravasation of macromolecules.22
Concerning dopamine, low-dose dopamine (4 µg · kg–1 ·
min–1) was demonstrated to enhance splanchnic blood,23
and an increase in intestinal blood flow by isoproterenol
was shown to increase the capillary filtration coefficient as
a result of an increase in microvascular filtration area.24
Accordingly, increased microvascular filtration can be
assumed to occur during low-dose dopamine administra-
tion, at least in the splanchnic circulation.
On the other hand, different types of anesthesia
(halothane and pentobarbital) were shown to reduce the dis-
appearance rate of intravenous labeled albumin by 30% to
40% in normovolemic dogs25 because of their hemody-
namic action. Data on the effect of sufentanil-midazolam on
the escape rate of albumin are not available. Sufentanil-
midazolam is known, however, to have only minor hemo-
dynamic effects26 and therefore should not significantly
affect the disappearance rate of albumin.
Albumin Disappearance Rate After CPB
The present study gives no indication of an increased pro-
tein leakage after CPB. This does not exclude, however, an
increased microvascular permeability to protein.
Transvascular transport of macromolecules depends not
only on microvascular permeability but also on exchange
area and fluid filtration. The latter variables depend on the
microvascular perfusion, microvascular blood pressure, and
colloid osmotic pressure. The hemodynamic and colloid
osmotic pressure data after CPB, however, do not support a
compromised microvascular filtration compared with that at
baseline. Thus, it seems rather unlikely that the microves-
sels had become leaky to proteins after CPB.
Inflammatory Mediators and Microvascular Protein
Leakage
Inflammatory cytokines have been repeatedly shown to
increase capillary permeability to macromolecules.27-29
Accordingly, during sepsis and after the application of endo-
toxin, which are well known to activate inflammatory media-
tors, increased microvascular leakage of macromolecules has
been observed in patients30 and in experimental animals.31-33
Extracorporeal Circulation and Microvascular Protein
Leakage
The contact of blood with foreign surfaces during extracor-
poreal circulation (ECC) is well known to activate inflam-
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matory cytokines and the complement system,5 which in
turn should disturb the endothelial barrier function. Only
limited information is available, however, concerning the
effect of CPB or ECC on microvascular leakage of PPs. An
increased transvascular escape rate of albumin has been
described in patients after CPB.30 In experimental animals
after ECC without CPB, an increase in intestinal, pul-
monary, coronary, and global microvascular permeability to
proteins has been reported.31,34
The present results contradict these studies, but they are
in accordance with a recent animal study from our labora-
tory with CPB and cardioplegic cardiac arrest according to
the clinical standard protocol.11 Probably, the inflammatory
response in the present study was not sufficient to injure the
endothelial barrier to proteins, as opposed to other studies,
which showed increased microvascular protein leakage at
severalfold higher levels of inflammatory mediators after
CPB34,35 or ischemia-reperfusion of the lower body.36
Intravascular Protein Pool
In the present examination intravascular protein was
decreased by about 25% after CPB. This does not mean,
however, that there was an increased microvascular perme-
ability to proteins but may be related to several other fac-
tors. First, an unknown loss of plasma occurs during and
after the operation as the result of the surgical procedure
(eg, surgical blood loss, blood remaining in the CPB circuit,
and plasma loss caused by hemoconcentration in the cell
saver). Second, protein is trapped at the surfaces of the ECC
circuit,11,37 which was found to be in the order of 2 g dur-
ing 90 minutes for the circuit used in our institution.11
Third, the return of extravasated protein by lymph nodes is
reduced during anesthesia because lymph node transport by
the muscle pump is not present as the result of the immobi-
lization.25 Finally, protein is shifted to the extravascular
compartment early during CPB11 by an increased microvas-
cular filtration after hemodilution38 by the crystalloidal
priming volume of the ECC circuit, which increases
microvascular filtration pressure by decreasing plasma col-
loid osmotic pressure.
Conclusion
In recent years, the attractive hypothesis was proposed that
the inflammatory response to CPB in cardiac surgery
increases capillary leakiness and causes an enhanced
extravasation of proteins and fluid. The present data con-
firm the inflammatory response after CPB in patients under-
going elective CABG. The escape rate of albumin, however,
gives no indication of an increase in microvascular perme-
ability. Thus, a capillary leak triggered by the inflammatory
response after CPB seems rather unlikely. Nevertheless,
PPs may be shifted from the intravascular to the extravas-
cular compartment by means of an increased fluid filtration
during CPB as a consequence of hypooncotic hemodilution
by crystalloidal priming of the CPB circuit and the use of a
crystalloidal cardioplegic solution.
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Discussion
Dr Edward D. Verrier (Seattle, Wash). I have an academic
interest in this area. Did you notice any evidence of either weight
gain, differences in fluid administration, or other end-organ func-
tion, such as a difference in an alveolar oxygen gradient, creatinine
clearance, or lung compliance? If you take any inflammatory
mediators, such as IL-8, IL-6, or any of the anaphylactic toxins of
complement, each one of them, in almost any animal model, will
cause edema. They will create a change in either the Starling
forces or the membrane itself, leading to transcapillary extravasa-
tion of fluid. I am concerned that you might have a methodologi-
cal problem, even with the Evans blue dye or the timing of it,
because it is counterintuitive and it goes against most of our exper-
imental evidence.
Dr Tassani. I think these experimental situations in which the
inflammatory mediators are causing edema are mostly a problem
of the concentration. There have been several studies done in
patients with sepsis in which these inflammatory mediators are
manyfold higher, as during CPB, and more important, the duration
of the inflammatory mediators in sepsis is longer, more often sev-
eral days. In contrast, during CPB, the duration of elevated levels
of inflammatory mediators is only 1 to 2 hours, and the concen-
trations approach normal values very fast. What we are postulating
is that the capillary leakage, which is a clinical diagnosis found
often in operating on infants, is mostly the result of hemodilution
just to fluid transition and probably not a reaction or a result of the
inflammatory reaction.
Dr Michael C. Maxwell (Charlotte, NC). Most often when we
see capillary leak syndrome clinically, it is in patients who are on
the pump a long time, 2.5, 3.0, or 3.5 hours. Your average pump
time was 84 minutes. Did you analyze a subset that had longer
pump runs to see if that was an influence?
Dr Tassani. That is a very good comment. What we are trying
at the moment is to do the same study in a population of infants
with a long pump time. However, during the presented investiga-
tion, even a slight elevation of the Evans blue dye disappearance
rate should have been able to be measured with this rather reliable
and precise method.
